Review article
Cancer Patients During the COVID-19 Pandemic
Juraj Prejac
Full text: croatian pdf 75 Kb
page 249-253
downloads: 1.665
cite
APA 6th Edition
Prejac, J. (2020). Cancer Patients During the COVID-19 Pandemic. Medicus, 29 (2 COVID-19), 249-249. Retrieved from https://hrcak.srce.hr/index.php/244343
MLA 8th Edition
Prejac, Juraj. "Cancer Patients During the COVID-19 Pandemic." Medicus, vol. 29, no. 2 COVID-19, 2020, pp. 249-249. https://hrcak.srce.hr/index.php/244343. Accessed 16 Aug. 2024.
Chicago 17th Edition
Prejac, Juraj. "Cancer Patients During the COVID-19 Pandemic." Medicus 29, no. 2 COVID-19 (2020): 249-249. https://hrcak.srce.hr/index.php/244343
Harvard
Prejac, J. (2020). 'Cancer Patients During the COVID-19 Pandemic', Medicus, 29(2 COVID-19), pp. 249-249. Available at: https://hrcak.srce.hr/index.php/244343 (Accessed 16 August 2024)
Vancouver
Prejac J. Cancer Patients During the COVID-19 Pandemic. Medicus [Internet]. 2020 [cited 2024 August 16];29(2 COVID-19):249-249. Available from: https://hrcak.srce.hr/index.php/244343
IEEE
J. Prejac, "Cancer Patients During the COVID-19 Pandemic", Medicus, vol.29, no. 2 COVID-19, pp. 249-249, 2020. [Online]. Available: https://hrcak.srce.hr/index.php/244343. [Accessed: 16 August 2024]
Full text: english pdf 75 Kb
page 249-249
downloads: 247
cite
APA 6th Edition
Prejac, J. (2020). Cancer Patients During the COVID-19 Pandemic. Medicus, 29 (2 COVID-19), 249-249. Retrieved from https://hrcak.srce.hr/index.php/244343
MLA 8th Edition
Prejac, Juraj. "Cancer Patients During the COVID-19 Pandemic." Medicus, vol. 29, no. 2 COVID-19, 2020, pp. 249-249. https://hrcak.srce.hr/index.php/244343. Accessed 16 Aug. 2024.
Chicago 17th Edition
Prejac, Juraj. "Cancer Patients During the COVID-19 Pandemic." Medicus 29, no. 2 COVID-19 (2020): 249-249. https://hrcak.srce.hr/index.php/244343
Harvard
Prejac, J. (2020). 'Cancer Patients During the COVID-19 Pandemic', Medicus, 29(2 COVID-19), pp. 249-249. Available at: https://hrcak.srce.hr/index.php/244343 (Accessed 16 August 2024)
Vancouver
Prejac J. Cancer Patients During the COVID-19 Pandemic. Medicus [Internet]. 2020 [cited 2024 August 16];29(2 COVID-19):249-249. Available from: https://hrcak.srce.hr/index.php/244343
IEEE
J. Prejac, "Cancer Patients During the COVID-19 Pandemic", Medicus, vol.29, no. 2 COVID-19, pp. 249-249, 2020. [Online]. Available: https://hrcak.srce.hr/index.php/244343. [Accessed: 16 August 2024]
Abstract
Patients with malignancies exposed to the SARS-CoV-2 virus may be at increased risk of developing a more severe clinical picture of COVID-19. This primarily refers to patients who are in active oncological treatment and are receiving chemotherapy, radiotherapy or other forms of specific treatment. To date, the diagnosis of the malignancy has been associated with an increased risk of developing a more severe form or even death from COVID-19. Furthermore, cancer patients may have an atypical presentation of the disease, while treatment complications may mimic COVID-19, such as pneumonitis and neutropenic fever. Moreover, lymphopenia, which is common in infections, may already be present as a result of chemotherapy. Given the above, clinical activities have been adapted to the circumstances surrounding the pandemic. Recommendations for physicians and patients include reducing patient and medical staff exposure, use of telemedicine, postponing outpatient non-urgent examinations, and adjusting the intensity and modality of administration of therapy when possible.
Keywords
COVID-19; pandemic; oncology; chemotherapy
Hrčak ID:
244343
URI
https://hrcak.srce.hr/244343
Publication date:
30.9.2020.
Article data in other languages:
croatian
Visits: 3.119
*